NxCare Participates In ERSP Forum

New York, NY – December 8, 2006 – The Electronic Retailing Self-Regulation Program (ERSP) has recommended that NxCare, Inc., marketers of the Methyl Ripped fat burner, discontinue product superiority claims and modify weight-loss related product performance claims. The marketer’s advertising was reviewed pursuant to an anonymous challenge.

ERSP,  the  electronic  direct-response  industry’s  self-regulatory  forum,  is  administered  by  the Council of Better Business Bureaus (CBBB) with policy oversight by the National Advertising Review Council (NARC).

ERSP reviewed the following core claims:

  • “Methyl Ripped-Rapid Fat Loss.”
  • “Methyl Ripped’s formula goes to work quickly obliterating fat.”

“No other fat burner can match Methyl Ripped’s combination of power, speed and effectiveness.  Combined with Methyl DRY and Methyl LEAN, to form the ripped system, you’ll burn fat and get shredded faster than ever.” “bodybuilding’s strongest fat burner”

Following its review of the evidence, ERSP determined that without comparative data against similar products in the marketplace, the superiority claims should be discontinued until the appropriate evidence has been provided.

ERSP determined that the testing results submitted did not support all reasonable interpretations communicated by the performance claims and recommended that the marketer modify or discontinue unqualified claims of rapid weight loss, particularly in conjunction with the claim that Methyl Ripped “goes to work quickly obliterating fat.”

ERSP recognized the marketer’s inclusion of the proper disclosure language accompanying consumer testimonials, but found that the text of the disclosure was of insufficient size. ERSP recommended the disclosure be made more clear and conspicuous. 

ERSP found the consumer testimonial (i.e., I needed to quickly lose fat, especially from my abs and waist”) to be a targeted weight-loss claim for which the marketer supplied no substantiation and recommended the marketer remove this claim from future advertising.

Finally, ERSP recommended that the marketer reconcile the discrepancy between the fat loss observed in its studies on Methyl Ripped’s individual ingredients versus the fat loss attributed by consumer testimonials to use of the product.

The company, in its marketer’s statement, said “NxCare appreciates ERSP’s careful consideration of the relevant science and its conclusion that Methyl Ripped has weight loss and rapid release properties. NxCare will closely consider ERSP’s recommendations on its claims and changes to future advertising that are consistent with this decision.”

 

Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.

 

 

 

 

Latest Decisions

Decision

National Advertising Division Finds Realtor.com “#1 Site Real Estate Professionals Trust” Claim Supported

New York, NY – November 8, 2024 – In a challenge brought by competitor CoStar Group, the National Advertising Division determined that Move provided a reasonable basis for its claim that Realtor.com is the “#1 site real estate professionals trust.

Read the Decision Summary
Decision

National Advertising Division Recommends Verizon Discontinue or Modify Certain Claims for Satellite-Supported Texting Services

New York, NY – November 7, 2024 – In a Fast-Track SWIFT challenge brought by T-Mobile, the National Advertising Division recommended that Verizon either discontinue certain claims about satellite-supported texting services in remote locations or modify them to disclose the necessary conditions for Verizon customers...

Read the Decision Summary
Decision

Following National Advertising Division Challenge, PetIQ Voluntarily Discontinues Certain Claims for NextStar Flea & Tick Topical

New York, NY – November 6, 2024 – Following a National Advertising Division challenge, PetIQ discontinued certain claims for its NextStar Flea & Tick topical flea prevention and treatment product, which appeared on PetIQ’s website, social media, and third-party websites.

Read the Decision Summary
Decision

National Advertising Division Finds Certain Safety Claims for Drunk Elephant Skincare Products Supported; Recommends Modification of Influencer Posts

New York, NY – November 4, 2024 – The National Advertising Division determined certain Drunk Elephant social media claims regarding skincare products being “safe for kids and tweens to use” were supported, but determined that two TikTok video influencer disclosures for Drunk Elephant's B-Goldi...

Read the Decision Summary